Procalcitonin as a biomarker for toxic shock syndrome

Acta Dermato-Venereologica

Volumn 90, Issue 4, 2010, Pages 441-443

  Kato, Madoka ^a,b   Kaneko, Sakae ^b   Takagaki, Kenji ^b   Kohayagawa, Yoshitaka ^b   Watanabe, Tessin ^a   Yoshida, Yuichi ^a   Yamamoto, Osamu ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b SHIMANE PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CEFACLOR; CLINDAMYCIN; LOXOPROFEN; MEROPENEM; PROCALCITONIN; STAPHYLOCOCCUS ENTEROTOXIN A; VANCOMYCIN; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ADULT; AXILLA; CASE REPORT; CONJUNCTIVA; DYSPNEA; ECHOCARDIOGRAPHY; EDEMA; ERYTHEMA; FEMALE; FEVER; HEADACHE; HEART FAILURE; HUMAN; HYPOTENSION; LETTER; MENSTRUATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NAUSEA; PHARYNX; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN DEFECT; SKIN PIGMENTATION; SKIN ULCER; TAMPON; THORAX RADIOGRAPHY; TOXIC SHOCK SYNDROME; VOMITING; BLOOD; COMPLICATION; DRUG COMBINATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME; UPREGULATION;

ADULT; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; CALCITONIN; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PROTEIN PRECURSORS; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME; UP-REGULATION;

EID: 77954909401     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0873     Document Type: Letter

References (10)

1. Todd J, Fishaut M, Kapral F, Welch T. Toxic-shock syndrome associated with phage-group-I staphylococci. Lancet 1978; 25: 1116-1118. (Pubitemid 9060056)
2. Mitaka C. Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. Clin Chim Acta 2005; 351: 17-29. (Pubitemid 39567312)
3. Marik PE. Definition of sepsis. Crit Care Med 2002; 30: 706-708.
4. Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 2000; 26: 148-152.
5. Lappin E, Ferguson AJ. Gram-positive toxic shock syndromes. Lancet Infect Dis 2009; 9: 281-290.
6. Todd JK. Toxic shock syndrome. Clin Microbiol Rev 1988; 1: 432-446.
7. Passeron T, Ndir MC, Aubron C, Hovette P. Drug rash with eosinophilia and systemic symptoms (DRESS) due to streptomycin. Acta Derm Venereol 2004; 84: 92-93. (Pubitemid 38168382)
8. Tofte RW, Williams DN. Toxic-shock syndrome. Evidence of a broad clinical spectrum. JAMA 1981; 246: 2163-2167.
9. Sfia M, Boeckler P, Lipsker D. High procalcitonin levels in patients with severe drug reactions. Arch Dermatol 2007; 143: 1591. (Pubitemid 350277786)
10. Fioretto JR, Borin FC, Bonatto RC, Ricchetti SM, Kurokawa CS, de Moraes M et al. Procalcitonin in children with sepsis and septic shock. J Pediatr 2007; 83: 323-328. (Pubitemid 47328113)